ClinicalTrials.gg

Program

lorundrostat

Also written as “lorundrostat Dose 1”, “lorundrostat Dose 2” and “Lorundrostat”.

Its studies are mostly in Hypertension · Sleep Apnea, Obstructive, led by Mineralys Therapeutics.

Furthest: phase 3, since Jul 14, 20234 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Mineralys Therapeutics41 open or runningphase 3since Jul 14, 2023Feb 24, 2023none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Feb 24, 2023First study: phase 2 study in HypertensionFirst studyNCT05769608 · 285 enrolled · United States
  2. Jul 14, 2023Phase 3 study in HypertensionNCT05968430 · 1,076 enrolled · United States, Australia, Bulgaria and more
  3. Nov 17, 2023Phase 3 study in HypertensionNCT06153693 · 1,083 enrolled · United States, Australia, Bulgaria and more
  4. Jan 16, 2025Phase 2 study in Sleep Apnea, ObstructiveNCT06785454 · 48 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06785454Sleep Apnea, Obstructive · United States2CompletedDec 17, 202548
NCT06153693Hypertension · United States, Australia, Bulgaria and more3CompletedDec 10, 20241,083
NCT05968430Hypertension · United States, Australia, Bulgaria and more3Active, not recruitingDec 30, 20251,076
NCT05769608Hypertension · United States2CompletedJan 15, 2025285

How it is read

Names in the registry

  • “lorundrostat Dose 1”, 2 entries
  • “lorundrostat Dose 2”, 2 entries
  • “lorundrostat”, 1 entry
  • “Lorundrostat”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.